drugset / Trial / NCT02414451

Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response

NCT02414451

RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to explore the effects of propranolol on social interaction, and secondarily on language, anxiety, adaptive behaviors, and global function in high functioning adults and adolescents with autism in a double-blinded, placebo-controlled pilot trial.

Timeline

Start
2016-09
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 100 mg Oral

Indications